- Lobbying
- foley AND hoag
Lobbying Arrangements Results for 'Foley Hoag'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues relating to the FDA regulation of humanitarian devices H.R. 3211 (Humanitarian Device Reform Act) and S. 1865 (Patient Access to Medical Innovation Act) FDA legislation and regulatory implem... |
Medtronic, Inc.
|
FOLEY HOAG LLP | |||
Details Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) |
Children's Hospital & Research Center Oakland
|
FOLEY HOAG LLP | |||
Details RD Drug Benefit Operations for Long Term Care Pharmacy Alliance Part D Program Implementation |
Long Term Care Pharmacy Alliance
|
FOLEY HOAG LLP | |||
Details Matters relating to healthcare associated infections Federal policies and legislations regarding utilization of diagnostic products and medical equipment; hospital-acquired infections Patient Prote... |
Becton Dickinson and Company
|
FOLEY HOAG LLP | |||
Details -Medicare coverage of home infusion drugs and biologics, including payment for durable medical equipment drugs and biologics -Implementation of 21st Century Cures (P.L. 114-255): Sec. 5012 - Medic... |
Shire
|
FOLEY HOAG LLP | |||
Details -Issues relating to gene therapy, value-based arrangements, and the Patient Affordability, Value and Efficacy (PAVE) Act. -Implementation of the Orphan Drug Act of 1983 (P.L. 97-414) and orphan dru... |
Bluebird Bio
|
FOLEY HOAG LLP | |||
Details Reauthorization of ESEA S. 1177 (Every Child Achieves Act of 2015). H.R. 5 (Student Success Act) |
Newsela
|
FOLEY HOAG LLP | |||
Details H.R. 307, Pandemic and All Hazards Preparedness Reauthorization Act; and Implementation of Project BioShield Act. Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8 S.... |
Chimerix, Inc.
|
FOLEY HOAG LLP | |||
Details Expanding patient access to medical devices and products. Legislative and regulatory matters affecting STEM education. H.R. 1249 America Invents Act of 2011; S. 23 Patent Reform Act of 2011 |
DEKA Research and Development Corporations
|
FOLEY HOAG LLP | |||
Details American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness... |
Partnership to Improve Patient Care
|
FOLEY HOAG LLP | |||
Details Senate and House comprehensive health reform bills; S.__ Affordable Health Choices Act Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physi... |
BIOTECHNOLOGY INDUSTRY ORGANIZATION
|
FOLEY HOAG LLP | |||
Details -General end-stage renal disease payment and reimbursement -Implementation of 21st Century Cures Legislation: Sec. 4013 - Telehealth Services in Medicare -Implementation of 21st Century Cures Legis... |
Baxter
|
FOLEY HOAG LLP | |||
Details Compensation for first responders exposed to toxins at the World Trade Center clean-up site |
Worby, Groner, Edelman & Napoli Bern
|
FOLEY HOAG LLP | |||
Details Cancer legislation issues |
Susan G. Komen Breast Cancer Foundation
Non-for-profit breast cancer patient and survivor advocacy group |
FOLEY HOAG LLP | |||
Details Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872) American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213) |
NOVARTIS
|
FOLEY HOAG LLP | |||
Details Lobbied the Executive Branch regarding support for Talisman in an Alien Tort Claims Act Case |
TALISMAN ENERGY INC
|
FOLEY HOAG LLP | |||
Details Colorectal Cancer Medicare and Reimbursement Issues; Screen Act--S. 1511 Supporting Colorectal Examination Now Act; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Ca... |
American College of Gastroenterology
|
FOLEY HOAG LLP | |||
Details Patent Reform S 515, HR 1260 Medicaid Rebate Issues FDA Globalization Act HR 759 Pharmaceutical coverage and reimbursement issues associated wtih American Recovery and Reinvestment Act of 2009 Foll... |
MedImmune, Inc.
|
FOLEY HOAG LLP | |||
Details Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) (Delivery System Reforms) |
Partners HealthCare System
|
FOLEY HOAG LLP | |||
Details Preserve Access to Affordable Generics Act - S.369 Patent Reform Act - S.515 Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Bios... |
Eisai Corporation of North America
|
FOLEY HOAG LLP | |||
Details Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of ... |
Organogenesis Inc.
Regenerative medicine company. |
FOLEY HOAG LLP | |||
Details S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementatio... |
GlaxoSmithKline
pharmaceutical company |
FOLEY HOAG LLP | |||
Details Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25) |
ASTRAZENECA PHARMACEUTICALS LP
|
FOLEY HOAG LLP | |||
Details Legislative and regulatory matters related to the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) with a focus on the coverage and reimbursement of novel... |
Orexigen Therapeutics, Inc.
|
FOLEY HOAG LLP | |||
Details Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Healt... |
Susan G. Komen For The Cure
Non-for-profit breast cancer patient and survivor advocacy group |
FOLEY HOAG LLP | |||
Details -Medicare payment and coding for clinical laboratory tests -Implementation of Protecting Access to Medicare Act of 2014 (P.L. 113-93) -Regulation of molecular diagnostics -Issues relating to Cure... |
Coalition for the 21st Century
|
FOLEY HOAG LLP | |||
Details Issues related to the Medical Device User Fee Program and to FDA regulated medical devices; issues related to the Regulation & Reimbursement of Diagnostics, regarding all provisions. Issues relate... |
Johnson and Johnson Services, Inc.
|
FOLEY HOAG LLP | |||
Details Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairn... |
American Orthotic & Prosthetic Association
|
FOLEY HOAG LLP | |||
Details Patent Reform - S 1145, HR 1908 FDA Globalization Act - HR 3610, S 3409 Follow-on Biologics -- S 1695, HR 1038, HR 1956 Physician Payments Sunshine Act: S 2029 |
BIOGEN IDEC, INC.
|
FOLEY HOAG LLP | |||
Details Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515 Medica... |
MERCK
|
FOLEY HOAG LLP | |||
Details Implementation of the Affordable Care Act of 2010 (Pub. L. 111-148) Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the Food and Drug Administration Safet... |
CUBIST PHARMACEUTICALS
|
FOLEY HOAG LLP | |||
Details - Issues related to OTC drug products. - Issues related to pseudoephedrine and acetaminophen. - Issues related to the regulation of cosmetic products. - H.R. 1078, Food and Drug Administration Sa... |
McNeil Consumer Healthcare LLC
Consumer healthcare products |
FOLEY HOAG LLP | |||
Details Pending healthcare legislation and potential impact on the biopharmaceutical industry. Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing an... |
GILEAD SCIENCES, INC
|
FOLEY HOAG LLP | |||
Details Medicare Part D Prescription Drug Benefit; Medicare coverage policy for chronic renal disease; Medicare Part B payment and coverage of dialysis products; Congressional deficit reduction negotiatio... |
AMGEN
|
FOLEY HOAG LLP | |||
Details Patent Reform Legislation - S 515, HR 1260 FDA Globalization Act - HR 759 Follow-on biologics - HR1427, HR 1548 Physician Payments Sunshine Act - S 301 ARRA; CER Medicare Improvements for Patients ... |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
|
FOLEY HOAG LLP | |||
Details S.510 FDA Food Safety Modernization Act; H.R. 2749 Food Safety Enhancement Act of 2009; S. 3307 Healthy, Hunger-Free Kids Act of 2010; H.R. 5504 Improving Nutrition for America's Children Act. H.R.... |
Abbott Laboratories
|
FOLEY HOAG LLP | |||
Details -Medicare Part B and D payment for drugs -Issues related to the repeal of the non-interference clause in Part D -Implementation of Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development ... |
Sanofi US Services, Inc.
|
FOLEY HOAG LLP |